Meanwhile,
Mucoviscidosis: how replace tobi podhaler:
To replace the Tobi Podhaler specialty 28 mg. For example, which is used with a inhaler in patients with cystic fibrosis, the Viatris laboratory offers its solution for inhalation by nebulizer. Meanwhile, An alternative to more than 2,000 euros, which also requires a change of equipment.
The specialty Tobi Podhaler 28 mg. However, presented in capsules for inhalation with a inhaler, is out of supply in town as in the hospital. In addition, Pending a quota delivery scheduled for the beginning of September. the Viatris laboratory, in accordance with the National Agency for the Safety of Medicines and Health Products (ANSM), recalls that its specialty Tobi 300 mg/5 ml in solution for inhalation by nebulizer remains available.
In practice. the replacement implies an adaptation of dosage and a change of equipment, with the provision for the patient of a suitable hand nebulizer. mucoviscidosis: how replace tobi podhaler In a letter addressed to healthcare professionals, Viatris helps make the transition:
As a reminder. the TOBI 300 mg/5 ml bulb must be emptied in the nebulizer and the administration by inhalation must last approximately 15 minutes. The product must be inhaled by the patient in a sitting. standing position, normally breathing through the oral part of the nebulizer. Nasal pliers can help the patient breathe through the mouth.
Tobi Podhaler (price excluding dispensation fees: € 2,206.18 euros) and Tobi solution to be nebuliser (price excluding dispensation fees: 2,103.11 euros) are indicated in patients with cystic fibrosis aged 6. over for long -term treatment of chronic pulmonary infections due to Pseudomonas aeruginosa.
Other specialties based on tobramycin by existing inhalation (Tobramycin Sun 300 mg/5 ml. Tobramycin Zentiva 300 mg/5 ml) are distributed in hospital circuit.
mucoviscidosis: how mucoviscidosis: how replace tobi podhaler replace tobi podhaler — Mucoviscidosis: how replace tobi podhaler: To replace the Tobi Podhaler specialty 28 mg. which is used with a inhaler in patients with cystic fibrosis, the Viatris laboratory offers its solution for inhalation by nebulizer. An alternative to more than 2,000 euros, which also requ.
Mucoviscidosis: how replace tobi podhaler
Further reading: To reduce obesity, eat less rather than move more? – The Efluelda anti-grip vaccine is back, the HAS recommends it – The COVVI-19 pandemic did not have a lasting impact in France – When hearing cancer can also “age” your healthy cells – which a revolutionary study reveals – World Hepatitis Day: Luxembourg intensifies its mobilization against a silent epidemic.